Lose 15% of your body weight with GLP-1s * Lose 15% of your body weight with GLP-1s * *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, the treatment group receiving semaglutide experienced a mean body weight loss of 15%, compared to 2% of the placebo group
As shown in Figure 6, the blood chemistry panels present pre- and post-treatment values for key clinical biomarkers collected at Day 0 prior to the injection and at Day 43 after the treatment, including hemoglobin A1c (HbA1c) ( Figure 6B ), aspartate aminotransferase (AST) ( Figure 6C ), alanine aminotransferase (ALT) ( Figure 6D ), total bilirubin ( Figure 6E ), creatinine ( Figure 6F ), and blood urea nitrogen (BUN) ( Figure 6G )
Since weight loss is the best medicine, GLP-1s that are approved for this use have given us a new tool to help a patients weight loss efforts in their pursuit to sleep soundly again.
These groups underwent continuous supplementation for 12 weeks